10° Congresso internazionale - Meeting on Pulmonary Rare Diseases and Orphan Drugs | IlPolmone.it

Presentazioni e materiale scientifico

03 Marzo 2023

In questa pagina pubblichiamo le presentazioni dei medici e degli addetti ai lavori intervenuti al 10° Congresso internazione - Pulmonary Rare Diseases and Orphan Drugs, tenutosi a Milano, il 3 e 4 marzo 2023 al Palazzo delle Stelline.
Per i dettagli sull'organizzazione e sul comitato scientifico visitate www.pulmonaryrarediseases.com

10th International Meeting on PULMONARY RARE DISEASES AND ORPHAN DRUGS
1.42 MB

Venerdì 3 marzo

ESC/ERS pulmonary hypertension guidelines: definition, classification and diagnosis. [Marion Delcroix]
5.35 MB

Treatment algorithm in pulmonary arterial hypertension [Olivier Sitbon]
5.9 MB

Angioplasty & Riociguat for the treatment of non-operable chronic thromboembolic pulmonary hypertension [Gerald Simonneau]
1.18 MB

Pulmonary hypertension associated with interstitial lung disease [Aaron Waxman]
5.05 MB

Pulmonary hypertension associated with COPD [Gabor Kovacs]
10.23 MB

Sarcoidosis-associated pulmonary hypertension [David Montani]
6.46 MB

Patients with idiopathic pulmonary fibrosis can improve with antifibrotic drugs? results from a retrospective study [Inas Awad + Equipe Harari]
734.7 KB

Short-term evolution of nutritional status in patients with Idiopathic Pulmonary Fibrosis [Giovanni Franco]
1.15 MB

Extracellular vesicles profile in bronchoalveolar lavage from IPF, HP and sarcoidosis patients: a multicenter study [Miriana D'Alessandro]
2.38 MB

Radiologic – pathologic correlation in 2-year follow up patients after SarsCov-2 infection [Cozzi Diletta]
11.16 MB

Safety/efficacy of rt234 vardenafil inhalation powder on exercise parameters in pulmonary arterial hypertension: phase 2 dose-escalation study design [Carol Satler]
436.56 KB

BENRALIZUMAB effects modulate nk cell maturation, proliferation, and activation in severe asthmatic patients [Laura Bergantini]
1.56 MB

PI*ZQ0ATTIKON GENOTYPE DEBUT IN ALPHA-1 ANTITRYPSIN DEFICIENCY [Manali]
1.7 MB

The ERS/ATS severe asthma guidelines Nicola Scichilone (Palermo, Italy)
1.78 MB

COVID and severe asthma Yochai Adir (Haifa, Israel)
1.25 MB

Biological therapies in type 2 asthma Enrico Heffler (Pieve Emanuele, Italy)
6.06 MB

Sabato 4 marzo

Interstitial pneumonitis with autoimmune features (IPAF): a good definition? [Elisabetta Renzoni]
1.32 MB

IMAGING IN ILD - CTD [Roberta Eufrasia Ledda]
7.32 MB

Should we forget immunosuppressive drugs? [Jean Marc Naccache]
2.12 MB

ILA: a clinical point of view [Sara Tomassetti]
3.94 MB

ILA: a radiological point of view [Maurizio Zompatori]
2.93 MB

New therapies of Fibrotic ILD [Fernando Martinez]
6.35 MB

New end points. Recent new primary end-points and the future [Athol Wells]
1.1 MB

Comorbidities in IPF: still things to learn [Antonella Caminati]
2.81 MB

New therapies for LAM [Sergio Harari]
1.67 MB

Sarcoidosis treatment practice guidelines [Katerina Antoniou]
8.23 MB